Biologics is an international, peer-reviewed, open access journal on all areas of biologics derived from both novel and established biotechnologies, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 27.7 days after submission; acceptance to publication is undertaken in 7.7 days (median values for papers published in this journal in the second half of 2023).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biologics, Molecules, Pharmaceuticals, Pharmaceutics
Biosimilars and Interchangeability Topic Editors: Alexis Oliva, Shein-Chung Chow, Joao Goncalves
Deadline: 31 December 2024
Special Issue in Biologics
Anti-SARS-CoV-2/COVID-19 Drugs and Vaccines: Part II Guest Editors: Vasso Apostolopoulos, Majid Davidson
Deadline: 30 June 2024
Special Issue in Biologics
The Role of Extracellular Vesicles in Cancer Guest Editor: Yasunari Matsuzaka
Deadline: 25 November 2024
Special Issue in Biologics
Progress in Antibody-Guided Vaccine Design for Viruses Guest Editor: Gary McLean
Deadline: 20 March 2025
Back to TopTop